Publication | Closed Access

Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis

NanoparticlesNanomedicineEngineeringInflammatory Lung DiseaseLung InflammationTherapeutic NanomaterialsImmunologySystemic Sclerosis PatientsPulmonary FibrosisNano-drug DeliveryTumor TargetingLung CancerImatinib-loaded Gold NanoparticlesMedicineRadiation OncologyTumor Microenvironment